Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 4
1997 2
1998 1
1999 2
2000 2
2001 3
2002 4
2003 7
2004 5
2005 3
2006 8
2007 15
2008 10
2009 10
2010 7
2011 8
2012 8
2013 10
2014 15
2015 8
2016 7
2017 5
2018 9
2019 6
2020 6
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard.
Kuten J, Fahoum I, Savin Z, Shamni O, Gitstein G, Hershkovitz D, Mabjeesh NJ, Yossepowitch O, Mishani E, Even-Sapir E. Kuten J, et al. J Nucl Med. 2020 Apr;61(4):527-532. doi: 10.2967/jnumed.119.234187. Epub 2019 Sep 27. J Nucl Med. 2020. PMID: 31562225
Re: Ofer Yossepowitch, Anders Bjartell, James A. Eastham, et al. Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences. Eur Urol 2009;55:87-99.
Kynaston H, Parker CC, Sydes MR; RADICALS Trial Management Group. Kynaston H, et al. Eur Urol. 2009 Jun;55(6):e107. doi: 10.1016/j.eururo.2009.03.022. Epub 2009 Mar 13. Eur Urol. 2009. PMID: 19303202 No abstract available.
Author Reply.
Tapiero S, Helfand A, Kedar D, Yossepowitch O, Nadu A, Baniel J, Lifshitz D, Margel D. Tapiero S, et al. Urology. 2018 Aug;118:112-113. doi: 10.1016/j.urology.2018.04.042. Epub 2018 Jun 6. Urology. 2018. PMID: 29886038 No abstract available.
Re: Multifocality in testicular germ cell tumors Y. Ehrlich, M. Konichezky, O. Yossepowitch and J. Baniel J Urol 2009, 181: 1114-1120.
Liu H, Sundquist J, Hemminki K. Liu H, et al. J Urol. 2010 Jun;183(6):2467-8. doi: 10.1016/j.juro.2010.02.036. Epub 2010 Apr 24. J Urol. 2010. PMID: 20417527 No abstract available.
Editorial Comment.
Yossepowitch O. Yossepowitch O. J Urol. 2020 Apr;203(4):765-766. doi: 10.1097/JU.0000000000000579.01. Epub 2019 Dec 26. J Urol. 2020. PMID: 31876449 No abstract available.
Positive surgical margins after radical prostatectomy: a systematic review and contemporary update.
Yossepowitch O, Briganti A, Eastham JA, Epstein J, Graefen M, Montironi R, Touijer K. Yossepowitch O, et al. Eur Urol. 2014 Feb;65(2):303-13. doi: 10.1016/j.eururo.2013.07.039. Epub 2013 Aug 3. Eur Urol. 2014. PMID: 23932439 Review.
Re: Prediagnosis prostate specific antigen velocity is associated with risk of prostate cancer progression following brachytherapy and external beam radiation therapy. S. E. Eggener, K. A. Roehl, O. Yossepowitch and W. J. Catalona, J Urol 2006; 176: 1399-1403.
Wagner MD, Daneshmand S, Sokoloff M, Barry JM. Wagner MD, et al. J Urol. 2007 Jun;177(6):2396; author reply 2396-7. doi: 10.1016/j.juro.2007.01.172. J Urol. 2007. PMID: 17509368 No abstract available.
Predicting 15-year prostate cancer specific mortality after radical prostatectomy.
Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ. Eggener SE, et al. J Urol. 2011 Mar;185(3):869-75. doi: 10.1016/j.juro.2010.10.057. Epub 2011 Jan 15. J Urol. 2011. PMID: 21239008 Free PMC article.
Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae.
Zohar I, Schwartz O, Yossepowitch O, David SSB, Maor Y. Zohar I, et al. J Antimicrob Chemother. 2020 Feb 1;75(2):458-465. doi: 10.1093/jac/dkz457. J Antimicrob Chemother. 2020. PMID: 31691817
The very-high-risk prostate cancer: a contemporary update.
Mano R, Eastham J, Yossepowitch O. Mano R, et al. Prostate Cancer Prostatic Dis. 2016 Dec;19(4):340-348. doi: 10.1038/pcan.2016.40. Epub 2016 Sep 13. Prostate Cancer Prostatic Dis. 2016. PMID: 27618950 Free PMC article. Review.
141 results
Jump to page
Feedback